Appendix J
Published Reports
June 2000

Breast Cancer and the Environment on Long Island
Marilie D. Gammon, Ph.D.
University of North Carolina at Chapel Hill, N.C.
(and formerly at Columbia University, New York, NY)

"Treatment for Breast Cancer and Blood Levels of Chlorinated Hydrocarbons," Marilie Gammon, Alfred Neugut, Mary Beth Terry, Julie Britton, Ellen Greenebaum, Hanina Hibshoosh, Bruce Levin, Qiao Wang, and Regina Santella, Columbia University, and Mary Wolff, Mt. Sinai School of Medicine, Cancer Epidemiology, Biomarkers & Prevention 5(6):467-471, June 1996.

This pilot study for the Columbia Case-Control Study was conducted to determine whether blood samples drawn prior to or after treatment for newly diagnosed breast cancer yielded significantly different estimates of cumulative exposure to DDE (metabolite of DDT) and PCBs. The researchers found that blood samples collected before and after treatment provided similar estimates of DDE exposure. However, use of blood samples after treatment for PCB analysis may lead to exposure inaccurate measurement or misclassification.

"Temporal Variation in Chlorinated Hydrocarbons in Health Women," Marilie Gammon, Alfred Neugut, Mary Beth Terry, Kyriakos Papodopoulos, Bruce Levin, Qiao Wang, and Regina Santella, Columbia University, and Mary Wolff, Mt. Sinai School of Medicine, Cancer Epidemiology, Biomarkers & Prevention 6(5):327-332, May 1997.

This pilot study for the Columbia Case-Control Study was conducted to determine the reliability of using one blood measurement for chlorinated hydrocarbons, or if there are short-term temporal variations in blood levels that suggest a need for additional measurement. The researchers found that a single measure for estimating exposure is reliable for DDE (metabolite of DDT) and PCBs.

"Proposed PCB Congener Groupings for Epidemiologic Studies," Mary Wolff, Mt. Sinai School of Medicine; David Camann, Southwest Research Institute; Marilie Gammon, Columbia University; and Steven Stellman, American Health Foundation; Environmental Health Perspectives 105(1):13-14, January 1997.

In preparation for the analysis of PCBs from dust in the home component of the Columbia Case-Control Study, as well as for application in other epidemiologic studies, the researchers suggest a possible set of PCB functional groups based on existing literature and structure activity considerations (for example, whether the PCB congener is estrogenic, antiestrogenic, or immunotoxic).

"Geographic exposure modeling: A valuable extension of geographic information systems for use in environmental epidemiology," by Jan Beyea, Consulting in the Public Interest, and Maureen Hatch, Mt. Sinai School of Medicine, Environmental Health Perspectives 10 (Supplement 1):181-190, February 1999.

top of page
Electromagnetic Fields and Breast Cancer on Long Island
M. Cristina Leske, M.D., M.P.H.
State University of New York at Stony Brook, NY

"Magnetic Field Exposure Assessment: A Comparison of Various Methods," Elinor Schoenfeld, Kevin Henderson, Erin O'Leary, Roger Grimson, and M. Cristina Leske, State University of New York at Stony Brook, NY; and William Kaune, EM Factors, Richland, Wash.; Bioelectromagnetics 20(8):487-496, December 1999.

"Breast Cancer and Electromagnetic Fields--A Review," Lee Caplan, Elinor Schoenfeld, Erin O'Leary, and Cristina Leske, State University of New York, Annals of Epidemiology 10(1):31-44, January 2000.

top of page
Epidemiology of Breast Cancer and Serum Organochlorine and
Serum Organochlorine Compounds and Breast Cancer on Long Island

Steven D. Stellman, Ph.D.
American Health Foundation, New York, NY

"Relative Abundance of Organochlorine Pesticides and Polychlorinated Biphenyls in Adipose Tissue and Serum of Women in Long Island, New York," Steven D. Stellman, Joshua Muscat, David Bernstein, Mirjana Djordjevic, and Lin Gong, American Health Foundation; Mark Citron, ProHEaltH Care Associates; Agnès White, Long Island Jewish Medical Center; Margaret Kemeny and Erna Busch, North Shore University Hospital; and Anne Nafziger, Bassett HealthCare, Cancer Epidemiology, Biomarkers & Prevention 7(6):489-496, June 1998.

Correspondence on above paper by J.D. Tessari and S.L.Archibeque-Engle, and by Steven D. Stellman, et al. in Cancer Epidemiology, Biomarkers & Prevention 8(1):111-114, January 1998 (abstract not available).

top of page
Organochlorine Compounds and Risk of Breast Cancer
Tongzhang Zheng, M.D., Sc.D.
Yale University, New Haven, CT

"Environmental Exposure to Hexachlorobenzene (HCB) and Risk of Female Breast Cancer in Connecticut," Tongzhang Zheng, Theodore Holford, Susan Mayne, Patricia Owens, Bin Zhang, Robert Dubrow, Barbara Ward, and Darryl Carter, Yale University School of Medicine; John Tessari, Colorado State University; Shelia Zahm, National Cancer Institute; and Peter Boyle, European Institute of Oncology; Cancer Epidemiology, Biomarkers & Prevention 8:407-411, May 1999.

"Beta-benzene Hexachloride in Breast Adipose Tissue and Risk of Breast Carcinoma," Tongzhang Zheng, Theodore Holford, Susan Mayne, Patricia Owens, Barbara Ward, Darryl Carter, and Robert Dubrow, Yale University School of Medicine; Shelia Zahm, National Cancer Institute; Peter Boyle, European Institute of Oncology; and John Tessari, Colorado State University; Cancer 85(10):2212-2218, May 15, 1999.

"DDE and DDT in Breast Adipose Tissue and Risk of Female Breast Cancer," Tongzhang Zheng, Theodore Holford, Susan Mayne, Barbara Ward, Darryl Carter, Patricia Owens, and Robert Dubrow, Yale Univeristy School of Medicine and Yale Cancer Center; Shelia Zahm, National Cancer Institute; Peter Boyle, European Institute of Oncology; and John Tessari, Colorado State University; American Journal of Epidemiology 150:5;453-458, September 1, 1999.

"Risk of Female Breast Cancer Associated with Serum Polychlorinated Biphenyls and 1,1-dichloro-2,2'-bis(p-chlrophenyl)ethylene," Tongzhang Zheng, Theodore Holford, Susan Mayne, Barbara Ward, Darryl Carter, Patricia Owens, Robert Dubrow, and O. Dawood, Yale University School of Medicine and Yale Cancer Center; Peter Boyle, European Institute of Oncology; Shannon Archibeque-Engle and John Tessari, Colorado State University; and Shelia Zahm, National Cancer Institute; Cancer Epidemiology, Biomarkers & Prevention 9(2):167-74, February 2000.

top of page
Reducing Barriers to Use of Breast Cancer Screening
Dorothy S. Lane, M.D., Ph.D.
State University of New York at Stony Brook, NY

"Confirmatory Analysis of Opinions Regarding the Pros and Cons of Mammography," William Rakowski, Brown University; Anne Stoddard, University of Massachusetts at Amherst; Barbara Rimer, Duke University Medical Center; Sara Fox, RAND and University of California at Los Angeles; M. Robyn Andersen and Nicole Urban, Fred Hutchinson Cancer Research Center; Dorothy Lane, State University of New York at Stony Brook, Mary Costanza, University of Massachusetts Medical Center; Health Psychology 16(5):433-441, September 1997.

"Underusers of Mammogram Screening: Stage of Adoption in Five U.S. Subpopulations," Anne Stoddard and Jill Avrunin, University of Massachusetts at Amherst; Barbara Rimer and Isaac Lipkus, Duke University Medical Center; Dorothy Lane, State University of New York at Stony Brook; Sara Fox, RAND and University of California at Los Angeles; Roger Luckmann and Mary Costanza, University of Massachusetts Medical Center; Susan Sprachman, Mathematica Policy Research, Inc.; and Nicole Urban, Fred Hutchinson Cancer Research Center; Preventive Medicine 27(3):478-487, May-June 1998.

"Current Perspectives on Physician Barriers to Breast Cancer Screening," Dorothy Lane and Catherine R. Messina, State University of New York at Stony Brook, Journal of the American Board of Family Practice 12(1):8-15, January-February 1999.

top of page
Estrogen Metabolites as Biomarkers for Breast Cancer Risk
(Breast Cancer Risk and Inducibility of P450s)
H. Leon Bradlow, Ph.D., Strang Cancer Prevention Laboratory, New York, NY, and
Geoffrey Kabat, Ph.D., State University of New York at Stony Brook, NY

"Urinary Estrogen Metabolites and Breast Cancer: A Case-Control Study," Geoffrey Kabat, Chee Jen Chang, Joseph Sparano, Xiao-Ping Hu, Abbas Khalil, and Ruth Rosenblatt, Montefiore Medical Center; and Daniel Sepkovic and H. Leon Bradlow, Strang Cancer Research Laboratory; Cancer Epidemiology, Biomarkers & Prevention 6(7):505-509, July 1997.

top of page
Regulation of Scatter Factor Expression in Breast Cancer
Eliot M. Rosen, M.D., Ph.D., Long Island Jewish Medical Center,
Albert Einstein College of Medicine, New Hyde Park, NY

"Scatter Factor Protein Levels in Human Breast Cancers: Clinicopathology and Biological Correlations," Yan Yao, Liang Jin, Alexander Fuchs, Itzhak Goldberg, and Eliot Rosen, Albert Einstein College of Medicine, and Harold Hastings, Hofstra University, American Journal of Pathology 149(5):1707-1717, November 1996.

top of page
RDA Analysis of Breast Cancer
Michael H. Wigler, Ph.D.
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY

"Comparative Genomic Analysis of Tumors: Detection of DNA Losses and Amplification," Nikolai Lisitsyn, Natalia Lisitsina, Peer Barker, and Michael Wigler, Cold Spring Harbor Laboratory; Guido Dalbagni, Memorial Sloan-Kettering Cancer Center; Carissa Sanchez, University of Washington; and Marston Linehan, National Cancer Institute; Proceedings of the National Academy of Sciences 92(1):151-155, January 3, 1995.

top of page
New Statistical Methodology for Determining Cancer Clusters
Martin Kulldorff, Ph.D.
of the National Cancer Institute, Bethesda, Md.
(now at the University of Connecticut Health Center, School of Medicine, Farmington, CT)

"Breast Cancer Clusters in the Northeast United States: A Geographic Analysis," Martin Kulldorff, Eric Feuer, Barry Miller and Laurence Freedman, National Cancer Institute, American Journal of Epidemiology 146(2):161-170, July 15, 1997.


LIBCSP Home | Overview | Research Projects | Reports
Funding | Timeline | Statistics | Ad Hoc Advisors | GIS